daksh diabetic and cardiac, dalsh cardiac, daksh pharmaceuticals , daksh pharma panchkula, cardiac pcd franchise, daksh panchkula, cardiac medicine, heart medicine, nebidac 2.5, nebidac 5, nebidac h
Nebidac, Nebivolol 2.5 mg, Nebivolol, Nebidac-2.5, daksh, daksh diabetic and cardiac, daksh pharma panchkula, daksh diabetic and cardiac panchkula, pcd franchise, pcd franchise company in panchkula, daksh group, pharma companies, pharma products, franchise, speciality product
daksh diabetic and cardiac, dalsh cardiac, daksh pharmaceuticals , daksh pharma panchkula, cardiac pcd franchise, daksh panchkula, cardiac medicine, heart medicine, nebidac 2.5, nebidac 5, nebidac h
Nebidac, Nebivolol 5 mg + Hydrochlorothiazide 12.5 mg, Nebivolol, Hydrochlorothiazide Nebidac-H, daksh, daksh diabetic and cardiac, daksh pharma panchkula, daksh diabetic and cardiac panchkula, pcd franchise, pcd franchise company in panchkula, daksh group, pharma companies, pharma products, franchise, speciality product
daksh diabetic and cardiac, dalsh cardiac, daksh pharmaceuticals , daksh pharma panchkula, cardiac pcd franchise, daksh panchkula, cardiac medicine, heart medicine, nebidac 2.5, nebidac 5, nebidac h
Nebidac, Nebivolol 2.5 mg, Nebivolol, Nebidac-2.5, daksh, daksh diabetic and cardiac, daksh pharma panchkula, daksh diabetic and cardiac panchkula, pcd franchise, pcd franchise company in panchkula, daksh group, pharma companies, pharma products, franchise, speciality product
daksh diabetic and cardiac, dalsh cardiac, daksh pharmaceuticals , daksh pharma panchkula, cardiac pcd franchise, daksh panchkula, cardiac medicine, heart medicine, nebidac 2.5, nebidac 5, nebidac h
Nebidac, Nebivolol 5 mg + Hydrochlorothiazide 12.5 mg, Nebivolol, Hydrochlorothiazide Nebidac-H, daksh, daksh diabetic and cardiac, daksh pharma panchkula, daksh diabetic and cardiac panchkula, pcd franchise, pcd franchise company in panchkula, daksh group, pharma companies, pharma products, franchise, speciality product

NEBIDAC

TAB NEBIDAC 2.5 (Nebivolol 2.5 mg ) BILSTER 10 X 10
TAB NEBIDAC 5 (Nebivolol 5 mg ) BILSTER 10 X 10
TAB NEBIDAC-H (Nebivolol 5 mg +  Hydrochlorothiazide 12.5 mg ) BILSTER 10 X 10
Category: Tag:
Send Enquiry

Introduction:

NEBIDAC tablets contain Nebivolol, a highly selective beta-1 adrenergic receptor blocker with vasodilating properties. It is primarily used in the management of hypertension and chronic heart failure, offering dual benefits of heart rate control and improved vascular function. One variant also includes Hydrochlorothiazide, a thiazide diuretic, for enhanced blood pressure control.

Available in blister packaging (10 x 10 tablets) for optimal storage and patient compliance.

Product Variants & Composition:

TAB NEBIDAC 2.5
Composition: Nebivolol 2.5 mg
Packaging: Blister | 10 x 10 Tablets

TAB NEBIDAC 5
Composition: Nebivolol 5 mg
Packaging: Blister | 10 x 10 Tablets

TAB NEBIDAC-H
Composition: Nebivolol 5 mg + Hydrochlorothiazide 12.5 mg
Packaging: Blister | 10 x 10 Tablets

Key Benefits:

  • Highly cardioselective beta-blocker with nitric oxide-mediated vasodilation

  • Dual action: Reduces heart rate and dilates blood vessels for better blood pressure control

  • Improves vascular endothelial function, beneficial in diabetic and elderly patients

  • Combination with Hydrochlorothiazide enhances efficacy in moderate to severe hypertension

  • Lower risk of fatigue, metabolic disturbance, and sexual dysfunction compared to traditional beta-blockers

Indications:

  • Essential hypertension (monotherapy or combination)

  • Chronic stable heart failure (in suitable patients)

  • Patients with coexisting cardiovascular and metabolic disorders

Dosage & Administration:

  • Nebivolol 2.5–5 mg once daily, titrated based on blood pressure and heart rate response.

  • NEBIDAC-H: One tablet once daily, particularly when monotherapy is inadequate.

  • Dose adjustments may be needed in elderly patients or those with renal impairment.

Precautions & Warnings:

  • Caution in patients with bradycardia, heart block, or severe hepatic impairment

  • Monitor blood pressure, electrolytes, and renal function periodically

  • NEBIDAC-H should be used cautiously in gout, diabetes, or electrolyte disturbances

  • Not recommended during pregnancy or lactation without physician advice

Possible Side Effects:

  • Fatigue, headache, dizziness

  • Bradycardia, hypotension

  • Edema, cold extremities

  • With NEBIDAC-H: Possible electrolyte imbalance, increased urination, or muscle cramps

Conclusion:

The NEBIDAC range offers a modern, safe, and effective solution for managing hypertension and related cardiovascular conditions. With both monotherapy and combination options, it supports personalized treatment and improved long-term cardiovascular outcomes.

Note : Always Consult a physician before taking any medication, and do not rely solely on this information for medical advice.

For more such product information and similar product category Cardiac

You can also contact us  https://diabetes-cardiac.com/contact-us/

Related products